The role of atherosclerosis risk factors in development of coronary artery disease in young men


Aim. To determine distribution of different atherosclerosis risk factors and their correlation with severity of coronary arteries (CA) affection in young men.
Material and methods. A total of 235 males aged 28-45 years were examined with coronarography which detected more than 50% narrowing in one or several major CA in 200 patients (the study group with coronary artery disease), 35 males without coronary stenosis served control. Atherosclerosis risk factors, serum lipids, lipoprotein(a), fibrinogen, C-reactive protein (CRP) were assessed.
Results. Smoking and hyperlipidemia (HLE) were registered in the study group more frequently. The level of lipoprotein(a) above 30 mg/dl was recorded in 98 (49%) and 7 (20%) patients of the study and control group, respectively (p = 0.001). As shown by a correlation analysis, the number of affected CA was associated with smoking (r = 0.2; p < 0.001), HLE (r = 0.23; p < 0.001), concentration of total cholesterol (r = 0.23; p < 0.0.001), lipoprotein (a) (r = 0.26; p < 0.001) and CRP (r = 0.26; p < 0.05). The level of lipoprotein(a) in patients with myocardial infarction and occluded artery was significantly higher than in patients without myocardial infarction and non-occlusive CA affection.
Conclusion. The presence and severity of coronary atherosclerosis in young men with coronary artery disease are associated with smoking, HLE and high concentration of lipoprotein (a).


  1. Zhdanov V. S., Sternby N. H., Vikhert A. M., Galakhov I. E. Development of atherosclerosis over a 25 year period: an epidemiological autopsy study in males of 11 towns. Int. J. Cardiol. 1999; 68(1): 95-106.
  2. McGill H. C. Jr., McMahan C. A. Determinants of atherosclerosis in the young. Pathobiological Determinants of Atherosclerosis in Youth (PDAY) Research Group. Am. J. Cardiol. 1998; 82: 30T-36T.
  3. Yusuf S., Hawken S., Ounpuu S. et al. INTERHEART Study Investigators. Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the LNTERHEART study): case-control study. Lancet 2004; 364: 937-952.
  4. Campeau L. Grading of angina pectoris. Circulation 1975; 54: 522-523.
  5. Judkins M. P. Selective coronary arteriography. A percutaneous transfemoral technic. Radiology 1967; 89: 815-824.
  6. Friedewald W. T., Levy R. I., Fredrickson D. S. Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. l972; 18: 499-502.
  7. Dahlen G. H. Incidence of Lp(a) lipoprotein among populations. In: Scanu A. M., (ed.) Lipoprotein(a). San Diego, Calif: Academic Press Inc.; 1990; 151-173.
  8. Афанасьева О. И., Адамова И. Ю., Беневоленская Г. Ф., Покровский С. Н. Иммуноферментный метод определения липопротеида(а). Бюл. экспер. биол. 1995; 4: 398-401.
  9. Fournier J. A., Sanchez A., Quero J. et al. Myocardial infarction in men aged 40 years or less: a prospective clinical angiographic study. Clin. Cardiol. 1996; 19: 631-636.
  10. Klein L .W., Agarwal J. B., Herlich M. B. et al. Prognosis of symptomatic coronary artery disease in young adults aged 40 years or less. Am. J. Cardiol. 1987; 60: 1269-1272.
  11. Kannel W., McGee D., Castelli W. Latest perspectives on cigarette smoking and cardiovascular disease: the Framingham Study. J. Card. Rehabil. 1984; 1: 267-277.
  12. Krolewski A. S., Kosinski E. J., Warram J. H. et al. Magnitude and determinants of coronary artery disease in juvenile onset, insulin dependent diabetes mellitus. Am. J. Cardiol. 1987; 59: 750-755.
  13. Klag M. J., Ford D. E., Mead L. A. et al. Serum cholesterol in young men and subsequent cardiovascular disease. N. Engl. J. Med. l993; 328: 313-318.
  14. Isser H. S., Puri V. K., Narain V. S. et al. Lipoprotein(a) and lipid levels in young patients with myocardial infarction and their first-degree relatives. Indian Heart J. 2001; 53: 463-466.
  15. Gonzalez-Requejo A., Sanchez-Bayle M., Ruiz-Jarabo C. et al. Lipoprotein(a) and cardiovascular risk factors in a cohort of 6-year-old children. The Rivas-Vaciamadrid Study. Eur. J. Pediatr. 2003; 162: 572-575.
  16. Kavanagh T., Shephard R. J., Hamm L. F. et al. Risk profile and health awareness in male offspring of parents with premature coronary heart disease. J. Cardiopulm. Rehabil. 2000; 20(3): l72-179.
  17. Marcovina S. M., Koschinsky M. L., Albers J. J., Skarlatos S. Report of the National Heart, Lung, and Blood Institute Workshop on Lipoprotein(a) and Cardiovascular Disease: Recent advances and future directions. Clin. Chem. 2003; 49: 1785-1796.
  18. Fishbein M. C., Siegel R. J. How big are coronary atherosclerotic plaques that rupture? Circulation, 1996; 94: 2662-2666.
  19. Bolibar I., Thompson S. G., von Eckardstein A. et al. Dose-response relationships of serum lipid measurements with the extent of coronary stenosis. Strong, independent, and comprehensive. ECAT Angina Pectoris Study Group. Arterioscler. Thromb. Vasc. Biol. 1995; 15: 1035-1042.



Abstract: 181

Article Metrics

Metrics Loading ...


  • There are currently no refbacks.

Copyright (c) 2009 Ezhov M.V., Afanas'eva O.I., Kambegova A.A., Afanas'eva M.I., Trukhacheva E.P., Naumov V.G., Pokrovskiy S.N., Ezhov M.V., Afanasyeva O.I., Kambegova A.A., Afanasyeva M.I., Trukhacheva E.P., Naumov V.G., Pokrovsky S.N.

Creative Commons License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.

Address of the Editorial Office:

  • Novij Zykovskij proezd, 3, 40, Moscow, 125167

Correspondence address:

  • Novoslobodskaya str 31c4., Moscow, 127005, Russian Federation

Managing Editor:


© 2018-2021 "Consilium Medicum" Publishing house

This website uses cookies

You consent to our cookies if you continue to use our website.

About Cookies